EXPE
64
-8
STI
4
-2
AIG
78
-2
AIV
43
-11
UAL
64
4
VIX
44
-3
AFL
60
-2
HD
40
-3
SLG
42
-3
CA
19
-3
GOOGL
45
3
IRM
44
-2
CTAS
37
-3
BAC
56
-4
WEC
78
-2
GD
57
-2
CMS
55
-3
TAP
60
2
CFG
60
6
EQIX
53
-4
EXPE
64
-8
STI
4
-2
AIG
78
-2
AIV
43
-11
UAL
64
4
VIX
44
-3
AFL
60
-2
HD
40
-3
SLG
42
-3
CA
19
-3
GOOGL
45
3
IRM
44
-2
CTAS
37
-3
BAC
56
-4
WEC
78
-2
GD
57
-2
CMS
55
-3
TAP
60
2
CFG
60
6
EQIX
53
-4
Financhill
Back

Royal Bank of Canada Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
64

RY
Royal Bank of Canada

Last Price:
$113.65
Seasonality Move:
3.74%
Sell
48

SRPT
Sarepta Therapeutics

Last Price:
$74.08
Seasonality Move:
14.66%
Buy
64
Royal Bank of Canada (RY) is a Buy

Is Royal Bank of Canada a Buy, Sell or Hold?

  • The current Royal Bank of Canada [RY] share price is $113.60. The Score for RY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • RY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $74.10. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RY Stock Price Chart

What is Royal Bank of Canada's stock price today?

  • The Royal Bank of Canada share price today is $113.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RY is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $74.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

RY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.68 Sell
Relative Strength Index (14 RSI): 45.75 Sell
Chaikin Money Flow: 290799 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.21 - 119.11) Sell
Bollinger Bands (100): (116.76 - 124.58) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.7 Sell
Relative Strength Index (14 RSI): 27.9 Sell
Chaikin Money Flow: -367389 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.59 - 111.17) Sell
Bollinger Bands (100): (103.29 - 127.87) Sell

RY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.3 Buy
20-day SMA: 114.67 Sell
50-day SMA: 118.1 Sell
200-day SMA: 117.46 Sell
8-day EMA: 113.2 Buy
20-day EMA: 114.49 Sell
50-day EMA: 117.19 Sell
200-day EMA: 115.88 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.22 Sell
20-day SMA: 97.87 Sell
50-day SMA: 108.64 Sell
200-day SMA: 125.16 Sell
8-day EMA: 84.58 Sell
20-day EMA: 94.74 Sell
50-day EMA: 105.16 Sell
200-day EMA: 118.38 Sell

Royal Bank of Canada Earnings Growth & RY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.13 per share, an increase this year of $0.88 per share, and an increase next year of $0.66 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Royal Bank of Canada Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):